Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study
Graphical abstract
Keywords
Mild COVID-19
Moderate COVID-19
The proportion to severe status
Hanshiyi Formula
Traditional Chinese medicine
Cited by (0)
- 1
Jiaxing Tian, Shiyan Yan, Han Wang and Ying Zhang contributed equally to this study.
© 2020 Elsevier Ltd. All rights reserved.